No Data
No Data
JMP Securities Maintains Pharvaris(PHVS.US) With Buy Rating, Maintains Target Price $55
Why Pharvaris (PHVS) Is Advancing Today
JMP Securities Maintains Market Outperform on Pharvaris, Raises Price Target to $55
Pharvaris Analyst Ratings
JMP Securities Maintains Pharvaris(PHVS.US) With Buy Rating, Raises Target Price to $55
Analysts Offer Insights on Healthcare Companies: Stevanato Group (STVN), Galapagos (GLPG) and Pharvaris (PHVS)